Introduction:

It is estimated that around 350 million people have diabetes mellitus; 90% type 2 diabetes (DM2). The beneficial impact of bariatric surgery in its treatment has been relevant.

Objectives:

To review the scientific evidence and reach a consensus among endocrinologists and surgeons about metabolic surgery.

Material and methods:

Representatives from three medical societies and four surgical societies, endocrinologist and bariatric surgeons from Mexico gathered to review the scientific evidence regarding metabolic surgery. Preliminary electronic voting was conducted using statements with responses of “Yes” or “No”. Consensus was defined when two-thirds of the votes (67%) were achieved.

Results:

Sixty-eight percent of the participants agreed that conventional treatment is not enough to achieve an adequate control of DM2; 97% considered that gastrointestinal surgery must become part of the treatment of DM2, gastric bypass being the highest choice.

Conclusions:

It is the first consensus in Mexico on metabolic surgery summoned by the Health Department. Metabolic surgery is part of treatment algorithms for DM2 internationally. All the participants manifested a high degree of consensus on terminology, indications for application, a need to issue official positioning and the future of metabolic surgery.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )